{"id":1938,"date":"2025-03-11T10:36:07","date_gmt":"2025-03-11T10:36:07","guid":{"rendered":"https:\/\/drebruokyay.com\/?p=1938"},"modified":"2025-04-04T10:41:25","modified_gmt":"2025-04-04T09:41:25","slug":"sistemik-ilaclar-egzama","status":"publish","type":"post","link":"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/","title":{"rendered":"Egzama \u0130\u00e7in Sistemik \u0130la\u00e7lar: Sizin \u0130\u00e7in Uygun mu?"},"content":{"rendered":"<p>Atopik dermatit olarak da bilinen egzama, d\u00fcnya \u00e7ap\u0131nda milyonlarca ki\u015fiyi etkileyen kronik bir iltihapl\u0131 cilt rahats\u0131zl\u0131\u011f\u0131d\u0131r.<sup>1<\/sup> ka\u015f\u0131nt\u0131l\u0131, k\u0131rm\u0131z\u0131, \u015fi\u015f ve \u00e7atlam\u0131\u015f cilt, egzama hafif ila \u015fiddetli aras\u0131nda de\u011fi\u015febilir ve bundan muzdarip olanlar\u0131n ya\u015fam kalitesini \u00f6nemli \u00f6l\u00e7\u00fcde etkiler. Topikal tedaviler genellikle ilk savunma hatt\u0131 olsa da, bunlar\u0131n yeterli olmad\u0131\u011f\u0131 durumlar da vard\u0131r. Bu gibi durumlarda, sa\u011fl\u0131k uzmanlar\u0131 \u015funlar\u0131 d\u00fc\u015f\u00fcnebilir: <strong>Sistemik \u0130la\u00e7lar<\/strong> durumu etkili bir \u015fekilde y\u00f6netmek i\u00e7in. Bu kapsaml\u0131 rehber, ne zaman <strong>Sistemik \u0130la\u00e7lar<\/strong> Egzama tedavisinin gerekli bir par\u00e7as\u0131 haline gelmek i\u00e7in, mevcut farkl\u0131 t\u00fcrleri, faydalar\u0131n\u0131, risklerini ve hastalar\u0131n bilmesi gerekenleri ara\u015ft\u0131r\u0131yoruz.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"559\" src=\"https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-27-1024x559.png\" alt=\"\" class=\"wp-image-1940\" srcset=\"https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-27-1024x559.png 1024w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-27-300x164.png 300w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-27-768x419.png 768w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-27-18x10.png 18w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-27.png 1408w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 ez-toc-wrap-left counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">\u0130\u00e7indekiler<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"\u0130\u00e7indekiler Tablosunu A\u00e7\/Kapat\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Ge\u00e7i\u015f<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Understanding_the_Burden_of_Eczema\" >Egzama Y\u00fck\u00fcn\u00fc Anlamak<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#The_Role_of_Topical_Treatments_in_Eczema_Management\" >Egzama Tedavisinde Topikal Tedavilerin Rol\u00fc<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#When_Topical_Treatments_Fall_Short_Recognizing_the_Need_for_Systemic_Intervention\" >Topikal Tedaviler Yetersiz Kald\u0131\u011f\u0131nda: Sistemik M\u00fcdahaleye \u0130htiya\u00e7 Duyuldu\u011funu Anlamak<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Extensive_Body_Surface_Area_Involvement\" >Geni\u015f V\u00fccut Y\u00fczey Alan\u0131 Tutulumu<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Severe_and_Persistent_Symptoms\" >\u015eiddetli ve Kal\u0131c\u0131 Semptomlar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Frequent_and_Severe_Flare-Ups\" >S\u0131k ve \u015eiddetli Alevlenmeler<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Impact_on_Quality_of_Life\" >Ya\u015fam Kalitesi \u00dczerindeki Etkisi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Failure_of_Topical_Medications\" >Topikal \u0130la\u00e7lar\u0131n Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Complications_of_Eczema\" >Egzama Komplikasyonlar\u0131<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Introducing_Systemic_Medications_A_Body-Wide_Approach\" >Sistemik \u0130la\u00e7lar\u0131n Tan\u0131t\u0131lmas\u0131: V\u00fccut Geneline Y\u00f6nelik Bir Yakla\u015f\u0131m<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Types_of_Systemic_Medications_for_Eczema\" >Egzama \u0130\u00e7in Sistemik \u0130la\u00e7 T\u00fcrleri<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Oral_Corticosteroids\" >A\u011f\u0131zdan al\u0131nan kortikosteroidler<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Traditional_Immunosuppressants\" >Geleneksel Ba\u011f\u0131\u015f\u0131kl\u0131k Bask\u0131lay\u0131c\u0131lar<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Cyclosporine\" >Siklosporin<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Methotrexate\" >Metotreksat<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Azathioprine\" >Azatioprin<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Mycophenolate_Mofetil\" >Mikofenolat Mofetil<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Biologics\" >Biyolojikler<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Dupilumab\" >Dupilumab<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Tralokinumab\" >Tralokinumab<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Lebrikizumab\" >Lebrikizumab<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Oral_Janus_Kinase_JAK_Inhibitors\" >Oral Janus Kinaz (JAK) \u0130nhibit\u00f6rleri<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Upadacitinib\" >Upadacitinib<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Abrocitinib\" >Abrositinib<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#How_Systemic_Medications_Work_to_Treat_Eczema\" >Sistemik \u0130la\u00e7lar Egzamay\u0131 Tedavi Etmek \u0130\u00e7in Nas\u0131l \u00c7al\u0131\u015f\u0131r?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Benefits_of_Using_Systemic_Medications_for_Eczema\" >Egzama \u0130\u00e7in Sistemik \u0130la\u00e7 Kullanman\u0131n Faydalar\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Potential_Risks_and_Side_Effects_of_Systemic_Medications\" >Sistemik \u0130la\u00e7lar\u0131n Olas\u0131 Riskleri ve Yan Etkileri<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#The_Decision-Making_Process_When_are_Systemic_Medications_the_Right_Choice\" >Karar Alma S\u00fcreci: Sistemik \u0130la\u00e7lar Ne Zaman Do\u011fru Se\u00e7imdir?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Living_with_Eczema_and_Systemic_Medications\" >Egzama ve Sistemik \u0130la\u00e7larla Ya\u015famak<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#The_Future_of_Systemic_Eczema_Treatments\" >Sistemik Egzama Tedavilerinin Gelece\u011fi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/drebruokyay.com\/tr\/systemic-medications-eczema\/#Conclusion_Systemic_Medications_as_a_Vital_Tool_in_Eczema_Management\" >Sonu\u00e7: Sistemik \u0130la\u00e7lar Egzama Tedavisinde Hayati Bir Ara\u00e7t\u0131r<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Understanding_the_Burden_of_Eczema\"><\/span>Egzama Y\u00fck\u00fcn\u00fc Anlamak<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Tart\u0131\u015fmadan \u00f6nce <strong>Sistemik \u0130la\u00e7lar<\/strong>, egzama hastal\u0131\u011f\u0131n\u0131n \u00e7ok y\u00f6nl\u00fc y\u00fck\u00fcn\u00fc anlamak \u00e7ok \u00f6nemlidir. G\u00f6r\u00fcn\u00fcr cilt semptomlar\u0131n\u0131n \u00f6tesinde, egzama hastal\u0131\u011f\u0131 olan ki\u015filer genellikle uykuyu bozabilen, kayg\u0131 ve depresyona yol a\u00e7abilen ve g\u00fcnl\u00fck aktiviteleri etkileyebilen yo\u011fun ka\u015f\u0131nt\u0131 ya\u015farlar. Egzama hastal\u0131\u011f\u0131 olan \u00e7ocuklar okulda ve sosyal etkile\u015fimlerde zorluklarla kar\u015f\u0131la\u015fabilirken, yeti\u015fkinler i\u015f ve ki\u015fisel ya\u015famlar\u0131n\u0131n etkilendi\u011fini g\u00f6rebilirler. S\u00fcrekli ka\u015f\u0131nt\u0131 ve ka\u015f\u0131ma d\u00f6ng\u00fcs\u00fc cilt enfeksiyonlar\u0131na yol a\u00e7abilir, durumu daha da karma\u015f\u0131k hale getirebilir ve ek tedavi gerektirebilir.<\/p>\n\n\n\n<p>Egzaman\u0131n \u015fiddeti bireyler aras\u0131nda b\u00fcy\u00fck \u00f6l\u00e7\u00fcde de\u011fi\u015fir. Baz\u0131lar\u0131, re\u00e7etesiz sat\u0131lan ila\u00e7lar ve temel cilt bak\u0131m\u0131 ile kolayca y\u00f6netilebilen ara s\u0131ra hafif alevlenmeler ya\u015fayabilir. Ancak di\u011ferleri, v\u00fccudun geni\u015f b\u00f6lgelerini kaplayan, \u00f6nemli rahats\u0131zl\u0131\u011fa neden olan ve genel refahlar\u0131n\u0131 etkileyen kal\u0131c\u0131 ve \u015fiddetli egzama ile kar\u015f\u0131 kar\u015f\u0131yad\u0131r. Bu daha \u015fiddetli vakalarda <strong>Sistemik \u0130la\u00e7lar<\/strong> s\u0131kl\u0131kla kritik bir rol oynar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Role_of_Topical_Treatments_in_Eczema_Management\"><\/span>Egzama Tedavisinde Topikal Tedavilerin Rol\u00fc<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Kortikosteroidler ve kalsin\u00f6rin inhibit\u00f6rleri gibi topikal tedaviler, bir\u00e7ok ki\u015fi i\u00e7in egzama y\u00f6netiminin temel ta\u015f\u0131d\u0131r. Bu ila\u00e7lar, iltihab\u0131 azaltmak ve ka\u015f\u0131nt\u0131y\u0131 gidermek i\u00e7in do\u011frudan etkilenen cilde uygulan\u0131r. Yumu\u015fat\u0131c\u0131lar veya nemlendiriciler de cilt bariyerini korumak ve alevlenmeleri \u00f6nlemek i\u00e7in \u00f6nemlidir.<\/p>\n\n\n\n<p>Topikal kortikosteroidler, hafiften \u00e7ok g\u00fc\u00e7l\u00fcye kadar \u00e7e\u015fitli g\u00fc\u00e7lerde gelir. G\u00fc\u00e7 se\u00e7imi egzaman\u0131n \u015fiddetine ve yerine ba\u011fl\u0131d\u0131r. Kalsin\u00f6rin inhibit\u00f6rleri, \u00f6zellikle uzun s\u00fcreli kullan\u0131m ve y\u00fcz ve boyun gibi hassas b\u00f6lgelerde kortikosteroidlere bir alternatif sunar.<\/p>\n\n\n\n<p>Topikal tedaviler hafif ila orta \u015fiddette egzama i\u00e7in etkili olsa da, \u015fiddetli veya yayg\u0131n hastal\u0131\u011f\u0131 olan ki\u015filer i\u00e7in yeterli olmayabilir. Bu durumlarda, iltihap genellikle yaln\u0131zca topikal uygulamalarla yeterli \u015fekilde kontrol edilemeyecek kadar kapsaml\u0131d\u0131r. \u0130\u015fte bu noktada <strong>Sistemik \u0130la\u00e7lar<\/strong> ortaya \u00e7\u0131kar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"When_Topical_Treatments_Fall_Short_Recognizing_the_Need_for_Systemic_Intervention\"><\/span>Topikal Tedaviler Yetersiz Kald\u0131\u011f\u0131nda: Sistemik M\u00fcdahaleye \u0130htiya\u00e7 Duyuldu\u011funu Anlamak<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Birka\u00e7 g\u00f6sterge, topikal tedavilerin egzamay\u0131 etkili bir \u015fekilde y\u00f6netmek i\u00e7in yeterli olmayabilece\u011fini ve potansiyel olarak \u015fu ihtiyaca i\u015faret etti\u011fini g\u00f6steriyor: <strong>Sistemik \u0130la\u00e7lar<\/strong>:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Extensive_Body_Surface_Area_Involvement\"><\/span>Geni\u015f V\u00fccut Y\u00fczey Alan\u0131 Tutulumu<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Egzama v\u00fccudun y\u00fczey alan\u0131n\u0131n b\u00fcy\u00fck bir y\u00fczdesini etkiledi\u011finde, topikal ila\u00e7lar\u0131n uygulanmas\u0131 pratik olmayabilir ve yeterli rahatlama sa\u011flamayabilir. <strong>Sistemik \u0130la\u00e7lar<\/strong>\u00d6te yandan, v\u00fccudun her yerinde \u00e7al\u0131\u015farak, iltihab\u0131n olu\u015ftu\u011fu her yerde tedavi eder.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Severe_and_Persistent_Symptoms\"><\/span>\u015eiddetli ve Kal\u0131c\u0131 Semptomlar<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Egzama semptomlar\u0131, \u00f6zellikle yo\u011fun ka\u015f\u0131nt\u0131 ve yayg\u0131n d\u00f6k\u00fcnt\u00fc, topikal tedavilerin tutarl\u0131 ve uygun kullan\u0131m\u0131na ra\u011fmen devam ederse, daha etkili, sistemik bir yakla\u015f\u0131ma ihtiya\u00e7 duyuldu\u011funu g\u00f6sterebilir. Kontrol alt\u0131na al\u0131nmayan ka\u015f\u0131nt\u0131, uykuyu ve g\u00fcnl\u00fck i\u015fleyi\u015fi \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir ve daha geni\u015f bir rahatlama sa\u011flayabilen bir tedaviyi gerekli k\u0131labilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequent_and_Severe_Flare-Ups\"><\/span>S\u0131k ve \u015eiddetli Alevlenmeler<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>S\u0131k ve \u015fiddetli egzama alevlenmeleri ya\u015fayan ve tekrarlayan topikal kortikosteroid k\u00fcrleri gerektiren ki\u015filer, a\u015fa\u011f\u0131daki tedaviden faydalanabilir: <strong>Sistemik \u0130la\u00e7lar<\/strong> Altta yatan iltihab\u0131 kontrol alt\u0131na almaya ve bu ataklar\u0131n s\u0131kl\u0131\u011f\u0131n\u0131 ve yo\u011funlu\u011funu azaltmaya yard\u0131mc\u0131 olur.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Impact_on_Quality_of_Life\"><\/span>Ya\u015fam Kalitesi \u00dczerindeki Etkisi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Egzama bir ki\u015finin ya\u015fam kalitesini \u00f6nemli \u00f6l\u00e7\u00fcde etkiledi\u011finde, uykusunu, ruh halini, sosyal etkile\u015fimlerini veya g\u00fcnl\u00fck g\u00f6revlerini yerine getirme yetene\u011fini etkiledi\u011finde, <strong>Sistemik \u0130la\u00e7lar<\/strong> Daha iyi semptom kontrol\u00fc sa\u011flayabilece\u011fi ve genel refah\u0131 art\u0131rabilece\u011fi d\u00fc\u015f\u00fcn\u00fclebilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Failure_of_Topical_Medications\"><\/span>Topikal \u0130la\u00e7lar\u0131n Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Bir hasta sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131s\u0131n\u0131n re\u00e7eteledi\u011fi topikal ila\u00e7lar\u0131 \u00f6zenle kullanm\u0131\u015fsa ve egzama semptomlar\u0131nda yeterli iyile\u015fme g\u00f6rmemi\u015fse, bu, \u00f6rne\u011fin farkl\u0131 bir yakla\u015f\u0131m\u0131n \u00f6nerilmesi anlam\u0131na gelir. <strong>Sistemik \u0130la\u00e7lar<\/strong>, gerekli olabilir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Complications_of_Eczema\"><\/span>Egzama Komplikasyonlar\u0131<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Baz\u0131 durumlarda \u015fiddetli egzama, tekrarlayan cilt enfeksiyonlar\u0131 veya egzama herpetikum (\u015fiddetli bir viral enfeksiyon) gibi komplikasyonlara yol a\u00e7abilir. <strong>Sistemik \u0130la\u00e7lar<\/strong> Altta yatan iltihab\u0131 kontrol alt\u0131na almak ve bu komplikasyonlar\u0131 \u00f6nlemek veya y\u00f6netmek i\u00e7in gerekebilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Introducing_Systemic_Medications_A_Body-Wide_Approach\"><\/span>Sistemik \u0130la\u00e7lar\u0131n Tan\u0131t\u0131lmas\u0131: V\u00fccut Geneline Y\u00f6nelik Bir Yakla\u015f\u0131m<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Sistemik \u0130la\u00e7lar<\/strong> egzama i\u00e7in, a\u011f\u0131zdan veya enjeksiyonla al\u0131nan ve v\u00fccutta iltihab\u0131 azaltmak i\u00e7in \u00e7al\u0131\u015fan ila\u00e7lard\u0131r. Bu ila\u00e7lar genellikle, topikal tedavilere yeterli yan\u0131t vermeyen orta ila \u015fiddetli egzamas\u0131 olan ki\u015filer i\u00e7in ayr\u0131lm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>Birka\u00e7 t\u00fcr\u00fc vard\u0131r <strong>Sistemik \u0130la\u00e7lar<\/strong> egzamay\u0131 tedavi etmek i\u00e7in kullan\u0131l\u0131r, her birinin kendine \u00f6zg\u00fc etki mekanizmas\u0131, faydalar\u0131 ve olas\u0131 yan etkileri vard\u0131r. Se\u00e7im <strong>Sistemik \u0130la\u00e7lar<\/strong> egzama \u015fiddeti, hastan\u0131n genel sa\u011fl\u0131k durumu ve daha \u00f6nceki tedavilere verdi\u011fi yan\u0131t gibi \u00e7e\u015fitli fakt\u00f6rlere ba\u011fl\u0131d\u0131r.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"559\" src=\"https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-28-1024x559.png\" alt=\"\" class=\"wp-image-1941\" srcset=\"https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-28-1024x559.png 1024w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-28-300x164.png 300w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-28-768x419.png 768w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-28-18x10.png 18w, https:\/\/drebruokyay.com\/wp-content\/uploads\/2025\/04\/image-28.png 1408w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Types_of_Systemic_Medications_for_Eczema\"><\/span>Egzama \u0130\u00e7in Sistemik \u0130la\u00e7 T\u00fcrleri<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Oral_Corticosteroids\"><\/span>A\u011f\u0131zdan al\u0131nan kortikosteroidler<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Prednizon gibi oral kortikosteroidler, \u015fiddetli egzama alevlenmelerinden h\u0131zl\u0131 bir rahatlama sa\u011flayabilen g\u00fc\u00e7l\u00fc anti-inflamatuar ila\u00e7lard\u0131r. Ba\u011f\u0131\u015f\u0131kl\u0131k sistemini bask\u0131layarak, v\u00fccuttaki iltihab\u0131 azaltarak \u00e7al\u0131\u015f\u0131rlar.<\/p>\n\n\n\n<p>\u015eiddetli egzamalar\u0131n k\u0131sa s\u00fcreli tedavisinde olduk\u00e7a etkili olsalar da, oral kortikosteroidler kilo al\u0131m\u0131, ruh hali de\u011fi\u015fiklikleri, enfeksiyon riskinde art\u0131\u015f, kemik kayb\u0131 ve y\u00fcksek tansiyon gibi \u00f6nemli yan etki potansiyelleri nedeniyle genellikle uzun s\u00fcreli kullan\u0131m i\u00e7in \u00f6nerilmez. Bu nedenle, genellikle \u015fiddetli alevlenmeleri kontrol alt\u0131na almak i\u00e7in k\u0131sa s\u00fcreli kullan\u0131l\u0131rlar, genellikle di\u011fer uzun s\u00fcreli tedavilere ge\u00e7i\u015f i\u00e7in bir k\u00f6pr\u00fc g\u00f6revi g\u00f6r\u00fcrler. <strong>Sistemik \u0130la\u00e7lar<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Traditional_Immunosuppressants\"><\/span>Geleneksel Ba\u011f\u0131\u015f\u0131kl\u0131k Bask\u0131lay\u0131c\u0131lar<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Geleneksel ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131lar ba\u011f\u0131\u015f\u0131kl\u0131k sistemini genel olarak bask\u0131layarak egzama ile ili\u015fkili iltihab\u0131 azalt\u0131r. Bu ila\u00e7lar genellikle topikal tedavilere yan\u0131t vermeyen orta ila \u015fiddetli egzama i\u00e7in kullan\u0131l\u0131r. Egzama i\u00e7in kullan\u0131lan yayg\u0131n geleneksel ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131lar \u015funlard\u0131r:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cyclosporine\"><\/span>Siklosporin<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Siklosporin, egzama ile ili\u015fkili iltihaplanmada \u00f6nemli bir rol oynayan bir ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccresi t\u00fcr\u00fc olan T h\u00fccrelerinin aktivitesini inhibe ederek \u00e7al\u0131\u015fan bir ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131d\u0131r. \u015eiddetli egzamay\u0131 kontrol etmede etkili olabilir ancak b\u00f6brek sorunlar\u0131, y\u00fcksek tansiyon ve enfeksiyon riskinin artmas\u0131 gibi olas\u0131 yan etkiler nedeniyle dikkatli bir izleme gerektirir.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Methotrexate\"><\/span>Metotreksat<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Metotreksat, bazen \u015fiddetli egzamay\u0131 tedavi etmek i\u00e7in kullan\u0131lan ba\u015fka bir ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131d\u0131r. Ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri de dahil olmak \u00fczere v\u00fccuttaki belirli h\u00fccrelerin b\u00fcy\u00fcmesini engelleyerek \u00e7al\u0131\u015f\u0131r. Metotreksat\u0131n olas\u0131 yan etkileri aras\u0131nda karaci\u011fer sorunlar\u0131, akci\u011fer iltihab\u0131 ve kemik ili\u011fi bask\u0131lanmas\u0131 bulunur ve d\u00fczenli kan testleri gerektirir.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Azathioprine\"><\/span>Azatioprin<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Azatioprin, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinde DNA ve RNA \u00fcretimini engelleyerek \u00e7al\u0131\u015fan bir ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131d\u0131r. Egzama tedavisinde etkili olabilir ancak tam etkisini g\u00f6stermesi birka\u00e7 hafta ila birka\u00e7 ay s\u00fcrebilir. Yan etkileri aras\u0131nda mide bulant\u0131s\u0131, kusma, ishal ve enfeksiyon riskinde art\u0131\u015f say\u0131labilir. Olas\u0131 karaci\u011fer sorunlar\u0131 ve kemik ili\u011fi bask\u0131lanmas\u0131n\u0131n izlenmesi i\u00e7in d\u00fczenli kan testleri gereklidir.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mycophenolate_Mofetil\"><\/span>Mikofenolat Mofetil<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Mikofenolat mofetil, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinde DNA \u00fcretiminde rol oynayan bir enzimi inhibe ederek \u00e7al\u0131\u015fan bir ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131d\u0131r. Bazen \u015fiddetli egzamay\u0131 tedavi etmek i\u00e7in etiket d\u0131\u015f\u0131 kullan\u0131l\u0131r. Yayg\u0131n yan etkiler aras\u0131nda mide bulant\u0131s\u0131, kusma ve ishal gibi gastrointestinal sorunlar bulunur.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Biologics\"><\/span>Biyolojikler<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Biyolojikler daha yeni bir s\u0131n\u0131ft\u0131r <strong>Sistemik \u0130la\u00e7lar<\/strong> egzama geli\u015fiminde rol oynayan ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin belirli bile\u015fenlerini hedef alan. Bu hedefli yakla\u015f\u0131m, geleneksel imm\u00fcnos\u00fcpresanlara k\u0131yasla daha az yayg\u0131n yan etkiye yol a\u00e7abilir. Birka\u00e7 biyolojik, orta ila \u015fiddetli egzama tedavisi i\u00e7in onaylanm\u0131\u015ft\u0131r:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dupilumab\"><\/span>Dupilumab<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Dupilumab, egzamada g\u00f6r\u00fclen tip 2 inflamasyonun ba\u015fl\u0131ca itici g\u00fc\u00e7leri olan iki \u00f6nemli protein olan interl\u00f6kin-4 (IL-4) ve interl\u00f6kin-13&#039;\u00fcn (IL-13) etkisini bloke eden bir monoklonal antikor. Her iki haftada bir (veya daha y\u00fcksek dozda her d\u00f6rt haftada bir) deri alt\u0131 enjeksiyonla uygulan\u0131r. Dupilumab, genel olarak olumlu bir g\u00fcvenlik profiliyle egzama semptomlar\u0131n\u0131 azaltmada ve ya\u015fam kalitesini iyile\u015ftirmede \u00f6nemli bir etkinlik g\u00f6stermi\u015ftir. Yayg\u0131n yan etkiler aras\u0131nda enjeksiyon yeri reaksiyonlar\u0131 ve konjonktivit bulunur.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tralokinumab\"><\/span>Tralokinumab<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Tralokinumab, interl\u00f6kin-13&#039;\u00fc (IL-13) \u00f6zel olarak hedef alan ba\u015fka bir monoklonal antikor. Ayr\u0131ca her iki haftada bir deri alt\u0131 enjeksiyonla uygulan\u0131r. Klinik \u00e7al\u0131\u015fmalar, tralokinumab&#039;\u0131n cilt temizli\u011fi ve ka\u015f\u0131nt\u0131 azalmas\u0131 dahil olmak \u00fczere egzama semptomlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftirebilece\u011fini g\u00f6stermi\u015ftir. Yayg\u0131n yan etkiler aras\u0131nda \u00fcst solunum yolu enfeksiyonlar\u0131, konjonktivit ve enjeksiyon yeri reaksiyonlar\u0131 bulunur.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Lebrikizumab\"><\/span>Lebrikizumab<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Lebrikizumab, interl\u00f6kin-13&#039;e (IL-13) se\u00e7ici olarak ba\u011flanan, resept\u00f6r\u00fcne ba\u011flanmas\u0131n\u0131 engelleyen ve daha sonra a\u015fa\u011f\u0131 ak\u0131\u015f sinyallemesini inhibe eden bir monoklonal antikor. \u0130lk birka\u00e7 doz i\u00e7in her iki haftada bir deri alt\u0131 enjeksiyonla uygulan\u0131r, ard\u0131ndan bak\u0131m tedavisi olarak her d\u00f6rt haftada bir uygulan\u0131r. Klinik \u00e7al\u0131\u015fmalar, lebrikizumab&#039;\u0131n egzama belirtilerinde ve semptomlar\u0131nda \u00f6nemli iyile\u015fmelere yol a\u00e7abilece\u011fini g\u00f6stermi\u015ftir. Yayg\u0131n yan etkiler aras\u0131nda enjeksiyon yeri reaksiyonlar\u0131, konjonktivit ve ba\u015f a\u011fr\u0131s\u0131 bulunur.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Oral_Janus_Kinase_JAK_Inhibitors\"><\/span>Oral Janus Kinaz (JAK) \u0130nhibit\u00f6rleri<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Oral JAK inhibit\u00f6rleri bir s\u0131n\u0131ft\u0131r <strong>Sistemik \u0130la\u00e7lar<\/strong> Janus kinazlar\u0131n\u0131n (JAK&#039;lar) aktivitesini bloke ederek \u00e7al\u0131\u015fan, egzama ile ili\u015fkili olanlar da dahil olmak \u00fczere, iltihaplanmada rol oynayan \u00e7e\u015fitli sitokinlerin sinyal yollar\u0131nda \u00f6nemli bir rol oynayan bir enzim ailesi. Birka\u00e7 JAK inhibit\u00f6r\u00fc orta ila \u015fiddetli egzama tedavisi i\u00e7in onaylanm\u0131\u015ft\u0131r:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Upadacitinib\"><\/span>Upadacitinib<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Upadacitinib, g\u00fcnde bir kez oral yoldan al\u0131nan se\u00e7ici bir JAK1 inhibit\u00f6r\u00fcd\u00fcr. Klinik \u00e7al\u0131\u015fmalar, orta ila \u015fiddetli egzamas\u0131 olan yeti\u015fkinlerde ve ergenlerde cilt temizli\u011fini \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftirme, ka\u015f\u0131nt\u0131y\u0131 azaltma ve ya\u015fam kalitesini iyile\u015ftirmedeki etkinli\u011fini g\u00f6stermi\u015ftir. Yayg\u0131n yan etkiler aras\u0131nda \u00fcst solunum yolu enfeksiyonlar\u0131, mide bulant\u0131s\u0131, ba\u015f a\u011fr\u0131s\u0131 ve kan kreatinininde art\u0131\u015f yer alabilir.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Abrocitinib\"><\/span>Abrositinib<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Abrocitinib, g\u00fcnde bir kez oral yoldan uygulanan ba\u015fka bir se\u00e7ici JAK1 inhibit\u00f6r\u00fcd\u00fcr. \u00c7al\u0131\u015fmalar, abrocitinib&#039;in ka\u015f\u0131nt\u0131 dahil egzama belirtilerini ve semptomlar\u0131n\u0131 h\u0131zla iyile\u015ftirebilece\u011fini ve hem k\u0131sa hem de uzun vadeli tedavide etkili oldu\u011funu g\u00f6stermi\u015ftir. Yayg\u0131n yan etkiler aras\u0131nda mide bulant\u0131s\u0131, ba\u015f a\u011fr\u0131s\u0131, \u00fcst solunum yolu enfeksiyonlar\u0131 ve herpes simpleks enfeksiyonlar\u0131 bulunabilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Systemic_Medications_Work_to_Treat_Eczema\"><\/span>Sistemik \u0130la\u00e7lar Egzamay\u0131 Tedavi Etmek \u0130\u00e7in Nas\u0131l \u00c7al\u0131\u015f\u0131r?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Sistemik \u0130la\u00e7lar<\/strong> Egzama tedavisinde, hastal\u0131\u011f\u0131n altta yatan iltihab\u0131na ve cilt bariyeri i\u015flev bozuklu\u011funa katk\u0131da bulunan ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin farkl\u0131 y\u00f6nlerini hedef alarak \u00e7al\u0131\u015f\u0131r.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Oral Kortikosteroidler:<\/strong> Ba\u011f\u0131\u015f\u0131kl\u0131k sistemini geni\u015f \u00e7apta bask\u0131layarak iltihab\u0131 azalt\u0131r.<\/li>\n\n\n\n<li><strong>Geleneksel \u0130mm\u00fcns\u00fcpresanlar (Siklosporin, Metotreksat, Azatioprin, Mikofenolat Mofetil):<\/strong> T h\u00fccreleri gibi \u00e7e\u015fitli ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin aktivitesini bask\u0131lar ve i\u015flevlerine m\u00fcdahale eder.<\/li>\n\n\n\n<li><strong>Biyolojikler (Dupilumab, Tralokinumab, Lebrikizumab):<\/strong> Egzamadaki tip 2 inflamasyonu y\u00f6nlendiren anahtar sitokinlerin (IL-4 ve\/veya IL-13) etkisini spesifik olarak bloke eder.<\/li>\n\n\n\n<li><strong>Oral JAK \u0130nhibit\u00f6rleri (Upadacitinib, Abrocitinib):<\/strong> \u00c7oklu proinflamatuar sitokinlerin sinyal yollar\u0131nda rol alan JAK enzimlerinin aktivitesini inhibe eder.<\/li>\n<\/ul>\n\n\n\n<p>Bu ba\u011f\u0131\u015f\u0131kl\u0131k tepkilerini d\u00fczenleyerek, <strong>Sistemik \u0130la\u00e7lar<\/strong> Orta ila \u015fiddetli egzamas\u0131 olan bireylerin iltihab\u0131n\u0131 etkili bir \u015fekilde azaltabilir, ka\u015f\u0131nt\u0131y\u0131 giderebilir, cilt temizli\u011fini iyile\u015ftirebilir ve sonu\u00e7 olarak ya\u015fam kalitesini art\u0131rabilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Benefits_of_Using_Systemic_Medications_for_Eczema\"><\/span>Egzama \u0130\u00e7in Sistemik \u0130la\u00e7 Kullanman\u0131n Faydalar\u0131<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Topikal tedaviler yetersiz kald\u0131\u011f\u0131nda, <strong>Sistemik \u0130la\u00e7lar<\/strong> Egzama hastalar\u0131na \u00f6nemli faydalar sa\u011flayabilir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Geli\u015fmi\u015f Belirti Kontrol\u00fc:<\/strong> <strong>Sistemik \u0130la\u00e7lar<\/strong> Ka\u015f\u0131nt\u0131, k\u0131zar\u0131kl\u0131k, \u015fi\u015flik ve cilt kurulu\u011fu gibi egzama semptomlar\u0131n\u0131n \u015fiddetini etkili bir \u015fekilde azaltabilir.<\/li>\n\n\n\n<li><strong>Artan Cilt Temizli\u011fi:<\/strong> Bir\u00e7ok <strong>Sistemik \u0130la\u00e7lar<\/strong>\u00d6zellikle biyolojik ila\u00e7lar ve JAK inhibit\u00f6rleri ciltte belirgin bir temizli\u011fe yol a\u00e7arak d\u00f6k\u00fcnt\u00fcn\u00fcn yayg\u0131nl\u0131\u011f\u0131n\u0131 ve \u015fiddetini azaltabilir.<\/li>\n\n\n\n<li><strong>Alevlenmelerin S\u0131kl\u0131\u011f\u0131 ve \u015eiddetinin Azalt\u0131lmas\u0131:<\/strong> Belirli maddelerin uzun s\u00fcreli kullan\u0131m\u0131 <strong>Sistemik \u0130la\u00e7lar<\/strong> Egzama alevlenmelerinin \u00f6nlenmesine veya s\u0131kl\u0131\u011f\u0131n\u0131n ve \u015fiddetinin azalt\u0131lmas\u0131na yard\u0131mc\u0131 olabilir.<\/li>\n\n\n\n<li><strong>Ya\u015fam Kalitesinde Art\u0131\u015f:<\/strong> Egzama semptomlar\u0131n\u0131 kontrol ederek, <strong>Sistemik \u0130la\u00e7lar<\/strong> Uyku, ruh hali, sosyal kat\u0131l\u0131m ve genel refahta \u00f6nemli iyile\u015fmelere yol a\u00e7abilir.<\/li>\n\n\n\n<li><strong>Uzun Vadeli Y\u00f6netim Potansiyeli:<\/strong> Baz\u0131 <strong>Sistemik \u0130la\u00e7lar<\/strong>Geleneksel imm\u00fcnos\u00fcpresanlar, biyolojik ila\u00e7lar ve JAK inhibit\u00f6rleri gibi baz\u0131 ila\u00e7lar orta ila \u015fiddetli egzamalar\u0131n uzun s\u00fcreli tedavisinde kullan\u0131labilir.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Potential_Risks_and_Side_Effects_of_Systemic_Medications\"><\/span>Sistemik \u0130la\u00e7lar\u0131n Olas\u0131 Riskleri ve Yan Etkileri<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Bir yandan <strong>Sistemik \u0130la\u00e7lar<\/strong> olduk\u00e7a etkili olabilir, potansiyel riskleri ve yan etkilerinin fark\u0131nda olmak \u00f6nemlidir. Belirli yan etkiler kullan\u0131lan ilac\u0131n t\u00fcr\u00fcne ba\u011fl\u0131 olarak de\u011fi\u015fir.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Oral Kortikosteroidler:<\/strong> K\u0131sa vadeli yan etkiler aras\u0131nda ruh hali de\u011fi\u015fiklikleri, i\u015ftah art\u0131\u015f\u0131 ve s\u0131v\u0131 tutulumu yer alabilir. Uzun vadeli kullan\u0131m kilo al\u0131m\u0131, y\u00fcksek tansiyon, kemik kayb\u0131, diyabet ve enfeksiyon riskinde art\u0131\u015f gibi daha ciddi yan etkilere yol a\u00e7abilir.<\/li>\n\n\n\n<li><strong>Geleneksel Ba\u011f\u0131\u015f\u0131kl\u0131k Bask\u0131lay\u0131c\u0131lar:<\/strong> Siklosporin b\u00f6brek sorunlar\u0131na ve y\u00fcksek tansiyona neden olabilir. Metotreksat karaci\u011feri ve akci\u011ferleri etkileyebilir. Azatioprin ve mikofenolat mofetil gastrointestinal sorunlara neden olabilir ve enfeksiyon riskini art\u0131rabilir. Bu ila\u00e7larla kan testleri yoluyla d\u00fczenli izleme \u00e7ok \u00f6nemlidir.<\/li>\n\n\n\n<li><strong>Biyolojikler:<\/strong> Dupilumab, tralokinumab ve lebrikizumab gibi biyolojiklerin yayg\u0131n yan etkileri aras\u0131nda genellikle enjeksiyon yeri reaksiyonlar\u0131 ve konjunktivit bulunur. Genellikle g\u00fcvenli kabul edilse de, daha ciddi enfeksiyonlar veya alerjik reaksiyonlar i\u00e7in teorik bir risk vard\u0131r.<\/li>\n\n\n\n<li><strong>Oral JAK \u0130nhibit\u00f6rleri:<\/strong> Upadacitinib ve abrocitinib&#039;in yayg\u0131n yan etkileri aras\u0131nda \u00fcst solunum yolu enfeksiyonlar\u0131, mide bulant\u0131s\u0131, ba\u015f a\u011fr\u0131s\u0131 ve herpes simpleks enfeksiyonlar\u0131 yer alabilir. Ayr\u0131ca, \u00f6zellikle \u00f6nceden var olan risk fakt\u00f6rleri olan ki\u015filerde daha ciddi kardiyovask\u00fcler olaylar veya kan p\u0131ht\u0131lar\u0131 riskleri de olabilir.<\/li>\n<\/ul>\n\n\n\n<p>Hastalar\u0131n sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131yla olas\u0131 riskler ve faydalar hakk\u0131nda kapsaml\u0131 bir g\u00f6r\u00fc\u015fme yapmas\u0131 esast\u0131r.<sup>2<\/sup> her birinin <strong>Sistemik \u0130la\u00e7lar<\/strong> Tedaviye ba\u015flamadan \u00f6nce. Herhangi bir yan etkiyi y\u00f6netmek ve ilac\u0131n etkili bir \u015fekilde \u00e7al\u0131\u015ft\u0131\u011f\u0131ndan emin olmak i\u00e7in d\u00fczenli izleme ve takip de \u00f6nemlidir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Decision-Making_Process_When_are_Systemic_Medications_the_Right_Choice\"><\/span>Karar Alma S\u00fcreci: Sistemik \u0130la\u00e7lar Ne Zaman Do\u011fru Se\u00e7imdir?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Ba\u015flama karar\u0131 <strong>Sistemik \u0130la\u00e7lar<\/strong> for eczema is a collaborative one between the patient and their healthcare provider, typically a dermatologist. Several factors are considered during this process:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Egzaman\u0131n \u015eiddeti:<\/strong> <strong>Sistemik \u0130la\u00e7lar<\/strong> Genellikle topikal tedavilere yeterli yan\u0131t vermeyen orta ila \u015fiddetli egzama i\u00e7in ayr\u0131lm\u0131\u015ft\u0131r.<\/li>\n\n\n\n<li><strong>Ya\u015fam Kalitesine Etkisi:<\/strong> Egzama, optimal topikal tedaviye ra\u011fmen ki\u015finin g\u00fcnl\u00fck ya\u015fam\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiliyorsa, <strong>Sistemik \u0130la\u00e7lar<\/strong> d\u00fc\u015f\u00fcn\u00fclebilir.<\/li>\n\n\n\n<li><strong>Topikal Tedavilerin Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131:<\/strong> Bir hasta, re\u00e7ete edilen topikal ila\u00e7lar\u0131 d\u00fczenli olarak kullanmas\u0131na ra\u011fmen \u00f6nemli bir iyile\u015fme kaydedememi\u015fse, sistemik bir yakla\u015f\u0131m gerekli olabilir.<\/li>\n\n\n\n<li><strong>Alevlenmelerin S\u0131kl\u0131\u011f\u0131:<\/strong> Tekrarlayan topikal kortikosteroid k\u00fcrleri gerektiren s\u0131k ve \u015fiddetli alevlenmeler, bir <strong>Sistemik \u0130la\u00e7lar<\/strong> daha iyi uzun vadeli kontrol sa\u011flamak.<\/li>\n\n\n\n<li><strong>Hasta Tercihleri ve Ya\u015fam Tarz\u0131:<\/strong> Hastan\u0131n tercihleri, ya\u015fam tarz\u0131 ve belirli bir tedavi rejimine uyma yetene\u011fi de \u00f6nemli hususlard\u0131r. \u00d6rne\u011fin, baz\u0131 hastalar enjeksiyonlara g\u00f6re oral ila\u00e7lar\u0131 tercih edebilir veya tam tersi olabilir.<\/li>\n\n\n\n<li><strong>Genel Sa\u011fl\u0131k ve T\u0131bbi Ge\u00e7mi\u015f:<\/strong> Se\u00e7ilen tedavinin do\u011fru bir \u015fekilde uygulanmas\u0131n\u0131 sa\u011flamak i\u00e7in hastan\u0131n genel sa\u011fl\u0131k durumu, di\u011fer t\u0131bbi durumlar\u0131 ve mevcut ila\u00e7lar\u0131 dikkate al\u0131nacakt\u0131r. <strong>Sistemik \u0130la\u00e7lar<\/strong> g\u00fcvenli ve uygundur.<\/li>\n\n\n\n<li><strong>Olas\u0131 Riskler ve Faydalar:<\/strong> Her birinin potansiyel riskleri ve faydalar\u0131 hakk\u0131nda kapsaml\u0131 bir tart\u0131\u015fma <strong>Sistemik \u0130la\u00e7lar<\/strong> Hastan\u0131n bilin\u00e7li bir karar almas\u0131na yard\u0131mc\u0131 olmak i\u00e7in se\u00e7enek \u00f6nemlidir.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Living_with_Eczema_and_Systemic_Medications\"><\/span>Egzama ve Sistemik \u0130la\u00e7larla Ya\u015famak<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Ba\u015flang\u0131\u00e7 <strong>Sistemik \u0130la\u00e7lar<\/strong> egzama i\u00e7in, durumu y\u00f6netmede \u00f6nemli bir ad\u0131m olabilir. Hastalar\u0131n ger\u00e7ek\u00e7i beklentilere sahip olmas\u0131 ve sa\u011fl\u0131k ekibiyle yak\u0131n bir \u015fekilde \u00e7al\u0131\u015fmas\u0131 \u00f6nemlidir. \u0130\u015fte egzama ile ya\u015faman\u0131n baz\u0131 temel y\u00f6nleri <strong>Sistemik \u0130la\u00e7lar<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tedaviye Uyum:<\/strong> Almak \u00e7ok \u00f6nemlidir <strong>Sistemik \u0130la\u00e7lar<\/strong> tam olarak sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131s\u0131n\u0131n re\u00e7ete etti\u011fi \u015fekilde. Dozlar\u0131 ka\u00e7\u0131rmak veya t\u0131bbi tavsiye olmadan dozaj\u0131 de\u011fi\u015ftirmek ilac\u0131n etkinli\u011fini etkileyebilir ve potansiyel olarak yan etkilere yol a\u00e7abilir.<\/li>\n\n\n\n<li><strong>D\u00fczenli Takip Randevular\u0131:<\/strong> \u0130la\u00e7lar\u0131n etkinli\u011fini takip etmek, yan etkilerini y\u00f6netmek ve gerekti\u011finde tedavi plan\u0131nda ayarlamalar yapmak i\u00e7in dermatologla d\u00fczenli kontroller \u015fartt\u0131r.<sup>3<\/sup><\/li>\n\n\n\n<li><strong>Yan Etkilerin Tan\u0131nmas\u0131 ve Bildirilmesi:<\/strong> Hastalar, ila\u00e7lar\u0131n\u0131n olas\u0131 yan etkilerinin fark\u0131nda olmal\u0131d\u0131r. <strong>Sistemik \u0130la\u00e7lar<\/strong> ve yeni veya k\u00f6t\u00fcle\u015fen semptomlar\u0131n\u0131z\u0131 derhal sa\u011fl\u0131k uzman\u0131n\u0131za bildirin.<\/li>\n\n\n\n<li><strong>\u0130yi Bir Cilt Bak\u0131m\u0131n\u0131n S\u00fcrd\u00fcr\u00fclmesi:<\/strong> Hatta devam ederken bile <strong>Sistemik \u0130la\u00e7lar<\/strong>Cilt bariyerini desteklemek i\u00e7in, yumu\u015fat\u0131c\u0131lar\u0131n d\u00fczenli kullan\u0131m\u0131 ve nazik temizlik de dahil olmak \u00fczere iyi cilt bak\u0131m\u0131 uygulamaya devam etmek \u00f6nemlidir.<\/li>\n\n\n\n<li><strong>Tetikleyicileri Y\u00f6netme:<\/strong> Bilinen egzama tetikleyicilerini (\u00f6rne\u011fin baz\u0131 tahri\u015f edici maddeler veya alerjenler) belirlemek ve bunlardan ka\u00e7\u0131nmak, alevlenmelerin s\u0131kl\u0131\u011f\u0131n\u0131 azaltmaya yard\u0131mc\u0131 olabilir.<\/li>\n\n\n\n<li><strong>Destek Ar\u0131yorum:<\/strong> Egzama gibi kronik bir rahats\u0131zl\u0131kla ya\u015famak zor olabilir. Destek gruplar\u0131yla veya ruh sa\u011fl\u0131\u011f\u0131 uzmanlar\u0131yla ba\u011flant\u0131 kurmak de\u011ferli duygusal ve pratik destek sa\u011flayabilir.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Future_of_Systemic_Eczema_Treatments\"><\/span>Sistemik Egzama Tedavilerinin Gelece\u011fi<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Egzama tedavisi alan\u0131 s\u00fcrekli olarak geli\u015fmekte olup, devam eden ara\u015ft\u0131rmalar yeni ve yenilik\u00e7i \u00fcr\u00fcnlerin geli\u015ftirilmesine yol a\u00e7maktad\u0131r. <strong>Sistemik \u0130la\u00e7lar<\/strong>Bilim insanlar\u0131 egzama hastal\u0131\u011f\u0131nda rol oynayan karma\u015f\u0131k ba\u011f\u0131\u015f\u0131kl\u0131k yollar\u0131n\u0131 daha iyi anlamak i\u00e7in s\u00fcrekli olarak \u00e7al\u0131\u015f\u0131yor ve bu sayede daha iyi g\u00fcvenlik profillerine sahip, daha hedef odakl\u0131 ve etkili tedavilerin \u00f6n\u00fcn\u00fc a\u00e7\u0131yor.<\/p>\n\n\n\n<p>Geli\u015ftirme a\u015famas\u0131ndaki yeni tedaviler aras\u0131nda farkl\u0131 sitokinleri veya yollar\u0131 hedef alan ek biyolojikler ve yeni k\u00fc\u00e7\u00fck molek\u00fcl inhibit\u00f6rleri yer al\u0131yor. Bu geli\u015fmeler, orta ila \u015fiddetli egzama hastalar\u0131na daha fazla se\u00e7enek sunma ve ya\u015fam kalitelerini daha da iyile\u015ftirme konusunda umut vadediyor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion_Systemic_Medications_as_a_Vital_Tool_in_Eczema_Management\"><\/span>Sonu\u00e7: Sistemik \u0130la\u00e7lar Egzama Tedavisinde Hayati Bir Ara\u00e7t\u0131r<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Topikal tedaviler egzama y\u00f6netiminin temelini olu\u015fturmaya devam ederken, <strong>Sistemik \u0130la\u00e7lar<\/strong> Bu tedavilere yeterli yan\u0131t vermeyen orta ila \u015fiddetli hastal\u0131klar\u0131n kontrol\u00fcnde \u00f6nemli bir rol oynar. Kullanma karar\u0131 <strong>Sistemik \u0130la\u00e7lar<\/strong> \u00d6nemli bir konu olup, egzaman\u0131n \u015fiddeti, ya\u015fam kalitesi \u00fczerindeki etkisi, her bir ilac\u0131n potansiyel yararlar\u0131 ve riskleri ve hastan\u0131n bireysel ko\u015fullar\u0131n\u0131n dikkatli bir \u015fekilde de\u011ferlendirilmesini gerektirir.<\/p>\n\n\n\n<p>Bir dizi ile <strong>Sistemik \u0130la\u00e7lar<\/strong> Geleneksel imm\u00fcnos\u00fcpresanlar, biyolojikler ve oral JAK inhibit\u00f6rleri dahil olmak \u00fczere art\u0131k mevcut olan \u015fiddetli egzama hastalar\u0131 her zamankinden daha fazla se\u00e7ene\u011fe sahip. Bu ila\u00e7lar, zay\u0131flat\u0131c\u0131 semptomlardan \u00f6nemli \u00f6l\u00e7\u00fcde rahatlama sa\u011flayabilir, cilt temizli\u011fini iyile\u015ftirebilir ve genel refah\u0131 art\u0131rabilir.<\/p>\n\n\n\n<p>Egzama ile ya\u015f\u0131yorsan\u0131z ve mevcut tedavi plan\u0131n\u0131z\u0131n yeterli rahatlama sa\u011flamad\u0131\u011f\u0131n\u0131 d\u00fc\u015f\u00fcn\u00fcyorsan\u0131z, se\u00e7eneklerinizi bir dermatologla g\u00f6r\u00fc\u015fmeniz \u00f6nemlidir. Durumunuzu de\u011ferlendirebilir, <strong>Sistemik \u0130la\u00e7lar<\/strong> sizin i\u00e7in uygundur ve bireysel ihtiya\u00e7lar\u0131n\u0131z i\u00e7in en iyi tedavi yakla\u015f\u0131m\u0131n\u0131 bulman\u0131z i\u00e7in mevcut se\u00e7enekler aras\u0131nda gezinmenize yard\u0131mc\u0131 olur. Unutmay\u0131n, egzama&#039;n\u0131n etkili y\u00f6netimi bir yolculuktur ve do\u011fru tedavi plan\u0131 ile, <strong>Sistemik \u0130la\u00e7lar<\/strong> gerekti\u011finde ya\u015fam kalitenizde \u00f6nemli iyile\u015ftirmeler m\u00fcmk\u00fcnd\u00fcr.<\/p>\n\n\n\n<p>G\u00fcvendi\u011finiz Dr. Ebru Okyay&#039;\u0131n uzmanl\u0131\u011f\u0131n\u0131 ke\u015ffedin&nbsp;<a href=\"https:\/\/drebruokyay.com\/tr\/hakkimizda\/\" target=\"_blank\" rel=\"noreferrer noopener\">dermatolog<\/a>&nbsp;i\u00e7inde&nbsp;<a href=\"https:\/\/antalya.goturkiye.com\/homepage\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Antalya<\/a>. \u0130ster t\u0131bbi cilt sorunlar\u0131n\u0131z\u0131 gidermek, ister kozmetik tedavilerle do\u011fal g\u00fczelli\u011finizi art\u0131rmak isteyin, Dr. Okyay size yard\u0131mc\u0131 olmak i\u00e7in burada. Ki\u015fiselle\u015ftirilmi\u015f bak\u0131m ve geli\u015fmi\u015f tekniklerle, cilt hedeflerinize ula\u015fmak hi\u00e7 bu kadar kolay olmam\u0131\u015ft\u0131.<\/p>","protected":false},"excerpt":{"rendered":"<p>Egzama, di\u011fer ad\u0131yla atopik dermatit, d\u00fcnya \u00e7ap\u0131nda milyonlarca insan\u0131 etkileyen kronik bir iltihapl\u0131 cilt rahats\u0131zl\u0131\u011f\u0131d\u0131r. Ka\u015f\u0131nt\u0131l\u0131, k\u0131rm\u0131z\u0131, \u015fi\u015fmi\u015f ve \u00e7atlam\u0131\u015f cilt ile karakterize edilen egzama, hafiften \u015fiddetliye kadar de\u011fi\u015febilir ve bu rahats\u0131zl\u0131ktan muzdarip olanlar\u0131n ya\u015fam kalitesini \u00f6nemli \u00f6l\u00e7\u00fcde etkiler. Topikal tedaviler genellikle ilk savunma hatt\u0131 olsa da, bunlar\u0131n yeterli olmad\u0131\u011f\u0131 durumlar da vard\u0131r. Bu gibi durumlarda, sa\u011fl\u0131k uzmanlar\u0131 durumu etkili bir \u015fekilde y\u00f6netmek i\u00e7in Sistemik \u0130la\u00e7lar\u0131 d\u00fc\u015f\u00fcnebilirler. Bu kapsaml\u0131 k\u0131lavuz, Sistemik \u0130la\u00e7lar\u0131n egzama tedavisinin gerekli bir par\u00e7as\u0131 haline geldi\u011fi durumlar\u0131, mevcut farkl\u0131 t\u00fcrlerini, faydalar\u0131n\u0131, risklerini ve hastalar\u0131n bilmesi gerekenleri ele alacakt\u0131r. Egzaman\u0131n Y\u00fck\u00fcn\u00fc Anlamak Sistemik \u0130la\u00e7lar\u0131 tart\u0131\u015fmadan \u00f6nce, egzaman\u0131n \u00e7ok y\u00f6nl\u00fc y\u00fck\u00fcn\u00fc anlamak \u00e7ok \u00f6nemlidir. G\u00f6r\u00fcn\u00fcr cilt semptomlar\u0131n\u0131n \u00f6tesinde, egzamal\u0131 bireyler genellikle uykuyu bozabilen, kayg\u0131 ve depresyona yol a\u00e7abilen ve g\u00fcnl\u00fck aktiviteleri engelleyebilen yo\u011fun ka\u015f\u0131nt\u0131 ya\u015farlar. Egzamal\u0131 \u00e7ocuklar okulda ve sosyal etkile\u015fimlerde zorluklarla kar\u015f\u0131la\u015fabilirken, yeti\u015fkinler i\u015f ve \u00f6zel hayatlar\u0131n\u0131n etkilendi\u011fini g\u00f6rebilirler. S\u00fcrekli ka\u015f\u0131nt\u0131 ve t\u0131rmalama d\u00f6ng\u00fcs\u00fc cilt enfeksiyonlar\u0131na yol a\u00e7arak durumu daha da karma\u015f\u0131k hale getirebilir ve ek tedavi gerektirebilir. Egzaman\u0131n \u015fiddeti bireyler aras\u0131nda b\u00fcy\u00fck \u00f6l\u00e7\u00fcde de\u011fi\u015fir. Baz\u0131lar\u0131, re\u00e7etesiz ila\u00e7lar ve temel cilt bak\u0131m\u0131yla kolayca kontrol alt\u0131na al\u0131nabilen ara s\u0131ra hafif alevlenmeler ya\u015fayabilir. Bununla birlikte, di\u011ferleri v\u00fccudun geni\u015f b\u00f6lgelerini kaplayan, \u00f6nemli rahats\u0131zl\u0131\u011fa neden olan ve genel refahlar\u0131n\u0131 etkileyen kal\u0131c\u0131 ve \u015fiddetli egzama ile kar\u015f\u0131 kar\u015f\u0131ya kal\u0131rlar. Sistemik ila\u00e7lar\u0131n s\u0131kl\u0131kla kritik bir rol oynad\u0131\u011f\u0131 bu daha \u015fiddetli vakalarda, topikal tedaviler genellikle \u00f6nemli bir rol oynar. Egzama Y\u00f6netiminde Topikal Tedavilerin Rol\u00fc Kortikosteroidler ve kalsin\u00f6ron inhibit\u00f6rleri gibi topikal tedaviler, bir\u00e7ok birey i\u00e7in egzama y\u00f6netiminin temel ta\u015f\u0131d\u0131r. Bu ila\u00e7lar, iltihab\u0131 azaltmak ve ka\u015f\u0131nt\u0131y\u0131 gidermek i\u00e7in do\u011frudan etkilenen cilde uygulan\u0131r. Nemlendiriciler de cilt bariyerini korumak ve alevlenmeleri \u00f6nlemek i\u00e7in \u00f6nemlidir. Topikal kortikosteroidler, hafiften \u00e7ok g\u00fc\u00e7l\u00fcye kadar \u00e7e\u015fitli potansiyellerde bulunur. Potansiyel se\u00e7imi, egzaman\u0131n \u015fiddetine ve yerine ba\u011fl\u0131d\u0131r. Kalsineurin inhibit\u00f6rleri, \u00f6zellikle uzun s\u00fcreli kullan\u0131m ve y\u00fcz ve boyun gibi hassas b\u00f6lgelerde kortikosteroidlere alternatif sunar. Topikal tedaviler hafif ila orta \u015fiddetteki egzama i\u00e7in etkili olsa da, \u015fiddetli veya yayg\u0131n hastal\u0131\u011f\u0131 olan ki\u015filer i\u00e7in yeterli olmayabilir. Bu durumlarda, iltihaplanma genellikle yaln\u0131zca topikal uygulamalarla yeterince kontrol edilemeyecek kadar yayg\u0131nd\u0131r. \u0130\u015fte burada Sistemik \u0130la\u00e7lara ihtiya\u00e7 duyulur. Topikal Tedaviler Yetersiz Kald\u0131\u011f\u0131nda: Sistemik M\u00fcdahale \u0130htiyac\u0131n\u0131 Anlamak Birka\u00e7 g\u00f6sterge, topikal tedavilerin egzamay\u0131 etkili bir \u015fekilde y\u00f6netmek i\u00e7in yeterli olmayabilece\u011fini ve Sistemik \u0130la\u00e7lara potansiyel ihtiyac\u0131 i\u015faret etti\u011fini g\u00f6stermektedir: Geni\u015f V\u00fccut Y\u00fczey Alan\u0131 Etkilenmesi Egzama v\u00fccut y\u00fczeyinin b\u00fcy\u00fck bir y\u00fczdesini etkiledi\u011finde, topikal ila\u00e7lar\u0131n uygulanmas\u0131 pratik olmayabilir ve yeterli rahatlama sa\u011flamayabilir. Sistemik ila\u00e7lar ise v\u00fccudun tamam\u0131nda etki g\u00f6stererek iltihab\u0131n olu\u015ftu\u011fu her yerde tedavi ederler. \u015eiddetli ve Kal\u0131c\u0131 Semptomlar E\u011fer egzama semptomlar\u0131, \u00f6zellikle yo\u011fun ka\u015f\u0131nt\u0131 ve yayg\u0131n d\u00f6k\u00fcnt\u00fc, topikal tedavilerin tutarl\u0131 ve uygun kullan\u0131m\u0131na ra\u011fmen devam ediyorsa, daha g\u00fc\u00e7l\u00fc, sistemik bir yakla\u015f\u0131ma ihtiya\u00e7 duyuldu\u011funu g\u00f6sterebilir. Kontrol alt\u0131na al\u0131namayan ka\u015f\u0131nt\u0131, uyku ve g\u00fcnl\u00fck i\u015flevleri \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir ve daha geni\u015f bir rahatlama sa\u011flayabilecek bir tedaviyi gerektirir. S\u0131k ve \u015eiddetli Alevlenmeler S\u0131k ve \u015fiddetli egzama alevlenmeleri ya\u015fayan ve tekrarlayan topikal kortikosteroid k\u00fcrleri gerektiren ki\u015filer, altta yatan iltihab\u0131 kontrol alt\u0131na almak ve bu ataklar\u0131n s\u0131kl\u0131\u011f\u0131n\u0131 ve \u015fiddetini azaltmak i\u00e7in sistemik ila\u00e7lardan fayda g\u00f6rebilirler. Ya\u015fam Kalitesi \u00dczerindeki Etkisi Egzama, bir ki\u015finin ya\u015fam kalitesini \u00f6nemli \u00f6l\u00e7\u00fcde etkiliyorsa, uykusunu, ruh halini, sosyal etkile\u015fimlerini veya g\u00fcnl\u00fck i\u015fleri yapma yetene\u011fini etkiliyorsa, daha iyi semptom kontrol\u00fc sa\u011flamak ve genel refah\u0131 iyile\u015ftirmek i\u00e7in sistemik ila\u00e7lar d\u00fc\u015f\u00fcn\u00fclebilir. Topikal \u0130la\u00e7lar\u0131n Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131: E\u011fer bir hasta, sa\u011fl\u0131k uzman\u0131 taraf\u0131ndan re\u00e7ete edilen topikal ila\u00e7lar\u0131 \u00f6zenle kullanm\u0131\u015f ve egzama semptomlar\u0131nda yeterli iyile\u015fme g\u00f6rmemi\u015fse, bu durum Sistemik \u0130la\u00e7lar gibi farkl\u0131 bir yakla\u015f\u0131m\u0131n gerekli olabilece\u011fini d\u00fc\u015f\u00fcnd\u00fcr\u00fcr. Egzaman\u0131n Komplikasyonlar\u0131: Baz\u0131 durumlarda, \u015fiddetli egzama, tekrarlayan cilt enfeksiyonlar\u0131 veya egzama herpetikum (\u015fiddetli bir viral enfeksiyon) gibi komplikasyonlara yol a\u00e7abilir. Altta yatan iltihab\u0131 kontrol etmek ve bu komplikasyonlar\u0131 \u00f6nlemek veya y\u00f6netmek i\u00e7in Sistemik \u0130la\u00e7lar gerekebilir. Sistemik \u0130la\u00e7lar\u0131n Uygulanmas\u0131: V\u00fccut Genelinde Bir Yakla\u015f\u0131m: Egzama i\u00e7in sistemik ila\u00e7lar, a\u011f\u0131zdan veya enjeksiyon yoluyla al\u0131nan ve iltihab\u0131 azaltmak i\u00e7in v\u00fccutta \u00e7al\u0131\u015fan ila\u00e7lard\u0131r. Bu ila\u00e7lar genellikle topikal tedavilere yeterince yan\u0131t vermeyen orta ila \u015fiddetli egzamas\u0131 olan ki\u015filer i\u00e7in ayr\u0131lm\u0131\u015ft\u0131r. Egzamay\u0131 tedavi etmek i\u00e7in kullan\u0131lan \u00e7e\u015fitli Sistemik \u0130la\u00e7 t\u00fcrleri vard\u0131r ve her birinin kendine \u00f6zg\u00fc etki mekanizmas\u0131, faydalar\u0131 ve potansiyel yan etkileri vard\u0131r. Sistemik ila\u00e7 se\u00e7imi, egzaman\u0131n \u015fiddeti, hastan\u0131n genel sa\u011fl\u0131\u011f\u0131 ve \u00f6nceki tedavilere verdi\u011fi yan\u0131t gibi \u00e7e\u015fitli fakt\u00f6rlere ba\u011fl\u0131d\u0131r. Egzama i\u00e7in Sistemik \u0130la\u00e7 T\u00fcrleri: Oral Kortikosteroidler Prednizon gibi oral kortikosteroidler, \u015fiddetli egzama ataklar\u0131ndan h\u0131zl\u0131 bir \u015fekilde kurtulma sa\u011flayabilen g\u00fc\u00e7l\u00fc antiinflamatuar ila\u00e7lard\u0131r. Ba\u011f\u0131\u015f\u0131kl\u0131k sistemini bask\u0131layarak v\u00fccuttaki iltihab\u0131 azalt\u0131rlar. \u015eiddetli egzaman\u0131n k\u0131sa s\u00fcreli y\u00f6netimi i\u00e7in olduk\u00e7a etkili olsalar da, oral kortikosteroidler genellikle kilo al\u0131m\u0131, ruh hali de\u011fi\u015fiklikleri, enfeksiyon riskinde art\u0131\u015f, kemik kayb\u0131 ve y\u00fcksek tansiyon gibi \u00f6nemli yan etkiler potansiyeli nedeniyle uzun s\u00fcreli kullan\u0131m i\u00e7in \u00f6nerilmez. Bu nedenle, genellikle \u015fiddetli ataklar\u0131 kontrol alt\u0131na almak i\u00e7in k\u0131sa s\u00fcreli k\u00fcrler halinde, genellikle di\u011fer uzun s\u00fcreli sistemik ila\u00e7lara ge\u00e7i\u015f a\u015famas\u0131 olarak kullan\u0131l\u0131rlar. Geleneksel \u0130mm\u00fcnosupresanlar Geleneksel imm\u00fcnosupresanlar, ba\u011f\u0131\u015f\u0131kl\u0131k sistemini geni\u015f \u00e7apta bask\u0131layarak egzama ile ili\u015fkili iltihab\u0131 azalt\u0131rlar. Bu ila\u00e7lar genellikle topikal tedavilere yan\u0131t vermeyen orta ila \u015fiddetli egzama i\u00e7in kullan\u0131l\u0131r. Egzama i\u00e7in kullan\u0131lan yayg\u0131n geleneksel imm\u00fcnosupresanlar \u015funlard\u0131r: Siklosporin Siklosporin, egzama ile ili\u015fkili iltihaplanmada \u00f6nemli rol oynayan bir ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccresi t\u00fcr\u00fc olan T h\u00fccrelerinin aktivitesini inhibe ederek \u00e7al\u0131\u015fan bir imm\u00fcnosupresand\u0131r. \u015eiddetli egzaman\u0131n kontrol\u00fcnde etkili olabilir, ancak b\u00f6brek sorunlar\u0131, y\u00fcksek tansiyon ve enfeksiyon riskinde art\u0131\u015f gibi potansiyel yan etkiler nedeniyle dikkatli izleme gerektirir. Metotreksat Metotreksat, bazen \u015fiddetli egzamay\u0131 tedavi etmek i\u00e7in kullan\u0131lan ba\u015fka bir imm\u00fcnosupresand\u0131r. T h\u00fccrelerinin aktivitesini engelleyerek \u00e7al\u0131\u015f\u0131r.<\/p>","protected":false},"author":1,"featured_media":1939,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_daextam_enable_autolinks":"1","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[],"class_list":["post-1938","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-common-skin-diseases"],"_links":{"self":[{"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/posts\/1938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/comments?post=1938"}],"version-history":[{"count":1,"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/posts\/1938\/revisions"}],"predecessor-version":[{"id":1942,"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/posts\/1938\/revisions\/1942"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/media\/1939"}],"wp:attachment":[{"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/media?parent=1938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/categories?post=1938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drebruokyay.com\/tr\/wp-json\/wp\/v2\/tags?post=1938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}